The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

JNJ-42165279 is a selective inhibitor of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of fatty acid amides (FAA) including anandamide (AEA), palmitoylethanolamide (PEA), and N-oleoylethanolamide (OEA). We assessed the efficacy, safety, tolerability, pharmacokinetics,...

詳細記述

保存先:
書誌詳細
出版年:Neuropsychopharmacology
主要な著者: Schmidt, Mark E., Liebowitz, Michael R., Stein, Murray B., Grunfeld, Jennifer, Van Hove, Ilse, Simmons, W. Kyle, Van Der Ark, Peter, Palmer, James A., Saad, Ziad S., Pemberton, Darrel J., Van Nueten, Luc, Drevets, Wayne C.
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8115178/
https://ncbi.nlm.nih.gov/pubmed/33070154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-00888-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料